Kewaunee Scientific Corporation KEQU
34.02
(0.26)
(0.76%)
as of 25 Sep
- Market cap
- $99.3M
- P/E
- 11.9×
Follow KEQU
Growth Flags
show if company had growth for consecutive years
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
| 11.27% | 13.45% | 16.46% | 17.74% |
+8 more TTM periods Free account |
|
| 4.46% | 5.16% | 6.07% | 7.26% | ||
ROIC |
8.40% | 9.34% | 11.34% | 10.25% | |
Return on Tangible Assets |
10.47% | 12.11% | 14.31% | 12.91% | |
Average Days of Receivables |
76.63 | 76.03 | 68.66 | 75.45 | |
Free Cash Flow per Share |
3.78 | 5.13 | 6.65 | 1.79 | |
Free Cash Flow |
10.88 | 14.70 | 19.06 | 5.12 | |
Capital Expenditures |
(3.94) | (3.94) | (3.52) | (3.55) | |
Piotroski F-Score |
4.00 | 5.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
11.17% | 13.80% | 17.25% | 5.88% | |
Accounts Receivable Turnover |
4.82 | 4.66 | 5.16 | 5.66 | |
Accounts Payable Turnover |
8.27 | 8.15 | 8.49 | 9.18 | |
Inventory Turnover |
6.12 | 6.36 | 6.34 | 7.48 | |
Average Days of Payables |
39.73 | 40.66 | 42.19 | 40.85 | |
Days of Inventory on Hand |
54.89 | 55.29 | 58.73 | 64.00 | |
Tax Rate |
(0.26) | (0.24) | (0.27) | (0.24) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
1.26% | 0.75% | 0.69% | 0.64% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.80 | 1.94 | 2.04 | 0.74 | |
Depreciation/Fixed assets |
0.31 | 0.31 | 0.31 | 0.29 | |
Capex/Depreciation |
(0.57) | (0.57) | (0.50) | (0.53) | |
Revenue per Share |
96.26 | 98.50 | 100.40 | 99.62 | |
Operating CF per Share |
5.15 | 6.51 | 7.88 | 3.02 | |
Capex per Share |
(1.37) | (1.38) | (1.23) | (1.24) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
2.97% | 3.41% | 3.85% | 4.11% |
Columns are period end dates